May 13, 2025 - 15:07

GigaCloud Technology has reported a substantial increase in its marketplace activity, with Gross Merchandise Volume (GMV) surging by 56% year-over-year. This impressive growth reflects a robust expansion of both its seller and buyer base, indicating a thriving ecosystem that continues to attract new participants.
Despite facing challenges in the broader market, GigaCloud's performance highlights its resilience and potential for future growth. The company's strategic initiatives to enhance its platform and improve user experience are paying off, as evidenced by the rising engagement and transaction volume.
Investors are taking note of these developments, as the stock presents considerable upside potential. Analysts suggest that the combination of increased marketplace activity and a solid operational framework could position GigaCloud favorably in the competitive landscape. As the company continues to capitalize on its growth trajectory, stakeholders are optimistic about the long-term prospects for GCT stock.
April 10, 2026 - 03:59
Verneek's Deep Technology Tackles Retail IssuesThe retail sector is turning to sophisticated artificial intelligence to solve persistent operational challenges, with companies like Verneek at the forefront. According to its CEO, Dr. Nasrin...
April 9, 2026 - 12:09
California lawmaker introduces bill to help prevent, de-escalate police chases with new technologyIn a direct response to the dangers of high-speed police pursuits, a California lawmaker has introduced new legislation focused on de-escalation and prevention. The bill arrives amid heightened...
April 8, 2026 - 20:04
Omatic Releases Fourth Annual Nonprofit Technology Ecosystem Trends Report, Uncovers a Sector Drowning in Data—And the Struggle to Trust ItA comprehensive new survey of over 800 nonprofit professionals has uncovered a sector at a critical technological crossroads, grappling with an overwhelming influx of data while simultaneously...
April 8, 2026 - 08:38
Halozyme and Vertex sign deal for Hypercon technologyIn a significant move within the biopharmaceutical industry, Halozyme Therapeutics has entered into an exclusive worldwide partnership and licensing agreement with Vertex Pharmaceuticals. The multi...